Published in Gene Therapy Weekly, October 23rd, 2003
"The main rationale for cell-based therapies following spinal cord injury are:
ii) remyelination of regenerating axons; and
iii), local delivery of growth promoting molecules.
"A potential source to meet these requirements is adult neural progenitor cells, which were examined in the present study," scientists writing in the European Journal of Neuroscience report.
"Fibroblast growth factor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.